XML 43 R5.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Shareholders' Equity (Unaudited) - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Total
Balance at Dec. 31, 2024 $ 14 $ 13,577 $ (8,815) $ 4,776
Balance, shares at Dec. 31, 2024 13,736,597      
Fair value of vested restricted stock units 76 76
Net loss (1,262) (1,262)
Proceeds from the sale of pre-funded warrants, net of offering costs 3,056 3,056
Issuance of common shares upon the exercise of pre-funded warrants $ 2 2
Issuance of common shares upon the exercise of pre-funded warrants, shares 2,010,000      
Fair value of common shares to be issued for vendor advance and deferred offering costs 484 484
Fair value of common shares to be issued for vendor advance and deferred offering costs, shares 551,000      
Fair value of vested restricted stock units, shares 78,521      
Balance at Mar. 31, 2025 $ 16 17,193 (10,077) 7,132
Balance, shares at Mar. 31, 2025 16,376,118      
Balance at Dec. 31, 2024 $ 14 13,577 (8,815) 4,776
Balance, shares at Dec. 31, 2024 13,736,597      
Balance at Dec. 31, 2025 $ 21 20,582 (14,262) 6,341
Balance, shares at Dec. 31, 2025 20,821,353      
Issuance of common shares sold through the At the Market (ATM) offering, net of offering costs 367 367
Issuance of common shares sold through the At the Market (ATM) offering, net of offering costs, shares 589,845      
Fair value of vested restricted stock units 259 259
Net loss (1,654) (1,654)
Proceeds from the sale of pre-funded warrants, net of offering costs       367
Balance at Mar. 31, 2026 $ 21 $ 21,208 $ (15,916) $ 5,313
Balance, shares at Mar. 31, 2026 21,411,198